Michael D. Taylor, MD, PhD, is a pediatric neurosurgeon-scientist and internationally recognized expert in pediatric brain tumors. He serves as a Pediatric Neurosurgeon and Scientist at Baylor College of Medicine–affiliated Texas Children’s Hospital, where he is Director of the Texas Children’s Pediatric Brain Tumor Research Program and holds the Cyvia and Melvyn Wolff Chair of Pediatric Neuro-Oncology.

Dr. Taylor’s research focuses on the molecular genetics of medulloblastoma and ependymoma, two of the most common malignant pediatric brain tumors. His laboratory has helped define medulloblastoma as a group of biologically distinct diseases and has advanced the understanding of tumor development, metastasis, and clinical heterogeneity in pediatric brain cancers. More recently, his work has helped show that certain cerebellar tumors are disorders of early brain development, providing important insight into why these tumors most often arise in young children.

Dr. Taylor has authored more than 400 peer-reviewed publications in leading journals, including Nature, Science, Cell, Cancer Cell, and The Lancet Oncology. His work has been cited more than 70,000 times and has contributed to improved clinical understanding and treatment strategies for children with brain cancer.

Dr. Taylor earned his MD from the University of Western Ontario and his PhD from the University of Toronto. He completed his neurosurgery residency at the University of Toronto, followed by postdoctoral fellowships in Cancer Genomics at St. Jude Children’s Research Hospital and Functional Genomics at the University of Toronto.

At SLHMs, Dr. Taylor brings world-class expertise in pediatric neuro-oncology, cancer genomics, translational science, and clinical care to support the company’s mission of developing new therapeutic approaches for children with serious brain cancers.